UniProt ID | PTN6_HUMAN | |
---|---|---|
UniProt AC | P29350 | |
Protein Name | Tyrosine-protein phosphatase non-receptor type 6 | |
Gene Name | PTPN6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 595 | |
Subcellular Localization | Cytoplasm. Nucleus. In neurons, translocates into the nucleus after treatment with angiotensin II (By similarity). Shuttles between the cytoplasm and nucleus via its association with PDPK1.. | |
Protein Description | Modulates signaling by tyrosine phosphorylated cell surface receptors such as KIT and the EGF receptor/EGFR. The SH2 regions may interact with other cellular components to modulate its own phosphatase activity against interacting substrates. Together with MTUS1, induces UBE2V2 expression upon angiotensin II stimulation. Plays a key role in hematopoiesis.. | |
Protein Sequence | MVRWFHRDLSGLDAETLLKGRGVHGSFLARPSRKNQGDFSLSVRVGDQVTHIRIQNSGDFYDLYGGEKFATLTELVEYYTQQQGVLQDRDGTIIHLKYPLNCSDPTSERWYHGHMSGGQAETLLQAKGEPWTFLVRESLSQPGDFVLSVLSDQPKAGPGSPLRVTHIKVMCEGGRYTVGGLETFDSLTDLVEHFKKTGIEEASGAFVYLRQPYYATRVNAADIENRVLELNKKQESEDTAKAGFWEEFESLQKQEVKNLHQRLEGQRPENKGKNRYKNILPFDHSRVILQGRDSNIPGSDYINANYIKNQLLGPDENAKTYIASQGCLEATVNDFWQMAWQENSRVIVMTTREVEKGRNKCVPYWPEVGMQRAYGPYSVTNCGEHDTTEYKLRTLQVSPLDNGDLIREIWHYQYLSWPDHGVPSEPGGVLSFLDQINQRQESLPHAGPIIVHCSAGIGRTGTIIVIDMLMENISTKGLDCDIDIQKTIQMVRAQRSGMVQTEAQYKFIYVAIAQFIETTKKKLEVLQSQKGQESEYGNITYPPAMKNAHAKASRTSSKHKEDVYENLHTKNKREEKVKKQRSADKEKSKGSLKRK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | RWFHRDLSGLDAETL CCCCCCCCCCCHHHH | 41.41 | 23401153 | |
10 (in isoform 4) | Phosphorylation | - | 41.41 | 27251275 | |
12 (in isoform 3) | Phosphorylation | - | 5.18 | 24719451 | |
16 | Phosphorylation | LSGLDAETLLKGRGV CCCCCHHHHHCCCCC | 38.83 | 30108239 | |
19 | Acetylation | LDAETLLKGRGVHGS CCHHHHHCCCCCCCE | 50.07 | 25953088 | |
19 | Ubiquitination | LDAETLLKGRGVHGS CCHHHHHCCCCCCCE | 50.07 | 21906983 | |
19 (in isoform 1) | Ubiquitination | - | 50.07 | 21890473 | |
21 (in isoform 3) | Ubiquitination | - | 42.23 | 21890473 | |
26 | Phosphorylation | KGRGVHGSFLARPSR CCCCCCCEEEECCCC | 11.38 | 23401153 | |
26 (in isoform 4) | Phosphorylation | - | 11.38 | 27251275 | |
32 | Phosphorylation | GSFLARPSRKNQGDF CEEEECCCCCCCCCE | 50.78 | 30108239 | |
34 | Ubiquitination | FLARPSRKNQGDFSL EEECCCCCCCCCEEE | 58.94 | - | |
40 | Phosphorylation | RKNQGDFSLSVRVGD CCCCCCEEEEEEECC | 25.19 | 30108239 | |
42 | Phosphorylation | NQGDFSLSVRVGDQV CCCCEEEEEEECCEE | 13.48 | 30108239 | |
57 | Phosphorylation | THIRIQNSGDFYDLY EEEEECCCCCCCCCC | 24.30 | 30108239 | |
57 (in isoform 4) | Phosphorylation | - | 24.30 | 27251275 | |
61 | Phosphorylation | IQNSGDFYDLYGGEK ECCCCCCCCCCCCEE | 15.13 | 28796482 | |
63 (in isoform 3) | Phosphorylation | - | 2.66 | 27642862 | |
64 | Phosphorylation | SGDFYDLYGGEKFAT CCCCCCCCCCEEEEE | 21.86 | 28796482 | |
66 (in isoform 3) | Phosphorylation | - | 22.74 | 25147952 | |
97 | Acetylation | DGTIIHLKYPLNCSD CCCEEEEEEECCCCC | 30.57 | 25953088 | |
97 | Ubiquitination | DGTIIHLKYPLNCSD CCCEEEEEEECCCCC | 30.57 | - | |
98 | Phosphorylation | GTIIHLKYPLNCSDP CCEEEEEEECCCCCC | 21.22 | - | |
111 | Phosphorylation | DPTSERWYHGHMSGG CCCCCCEEECCCCCC | 12.25 | - | |
116 | Phosphorylation | RWYHGHMSGGQAETL CEEECCCCCCCHHHH | 33.81 | 24247654 | |
138 | Phosphorylation | WTFLVRESLSQPGDF CEEEEEECCCCCCCE | 23.82 | 26657352 | |
140 | Phosphorylation | FLVRESLSQPGDFVL EEEEECCCCCCCEEE | 43.54 | 26657352 | |
140 (in isoform 4) | Phosphorylation | - | 43.54 | 27251275 | |
151 | O-linked_Glycosylation | DFVLSVLSDQPKAGP CEEEEEECCCCCCCC | 31.85 | 30379171 | |
155 | Ubiquitination | SVLSDQPKAGPGSPL EEECCCCCCCCCCCC | 61.41 | - | |
160 | Phosphorylation | QPKAGPGSPLRVTHI CCCCCCCCCCEEEEE | 24.72 | 25003641 | |
168 | Ubiquitination | PLRVTHIKVMCEGGR CCEEEEEEEEECCCC | 19.13 | - | |
176 | Phosphorylation | VMCEGGRYTVGGLET EEECCCCEEECCEEC | 14.73 | - | |
177 | Phosphorylation | MCEGGRYTVGGLETF EECCCCEEECCEECC | 16.00 | 22115753 | |
183 | Phosphorylation | YTVGGLETFDSLTDL EEECCEECCCHHHHH | 37.47 | 28450419 | |
186 | Phosphorylation | GGLETFDSLTDLVEH CCEECCCHHHHHHHH | 29.04 | 28450419 | |
188 | Phosphorylation | LETFDSLTDLVEHFK EECCCHHHHHHHHHH | 31.10 | 26657352 | |
195 | Ubiquitination | TDLVEHFKKTGIEEA HHHHHHHHHHCCHHC | 51.86 | - | |
196 | Ubiquitination | DLVEHFKKTGIEEAS HHHHHHHHHCCHHCC | 51.55 | - | |
213 | Phosphorylation | FVYLRQPYYATRVNA EEEECCCCCEECCCH | 9.44 | - | |
214 | Phosphorylation | VYLRQPYYATRVNAA EEECCCCCEECCCHH | 14.26 | 25839225 | |
232 | Ubiquitination | NRVLELNKKQESEDT HHHHHHHCCCCCHHH | 69.34 | - | |
233 | Ubiquitination | RVLELNKKQESEDTA HHHHHHCCCCCHHHH | 59.22 | - | |
236 | Phosphorylation | ELNKKQESEDTAKAG HHHCCCCCHHHHHHC | 37.97 | 30624053 | |
238 (in isoform 2) | Ubiquitination | - | 62.33 | 21890473 | |
241 | Ubiquitination | QESEDTAKAGFWEEF CCCHHHHHHCHHHHH | 51.65 | - | |
250 | O-linked_Glycosylation | GFWEEFESLQKQEVK CHHHHHHHHHHHHHH | 41.23 | 30379171 | |
250 | Phosphorylation | GFWEEFESLQKQEVK CHHHHHHHHHHHHHH | 41.23 | 28450419 | |
250 (in isoform 4) | Phosphorylation | - | 41.23 | 27251275 | |
253 | Ubiquitination | EEFESLQKQEVKNLH HHHHHHHHHHHHHHH | 54.44 | - | |
257 | Ubiquitination | SLQKQEVKNLHQRLE HHHHHHHHHHHHHHC | 53.70 | - | |
271 | Ubiquitination | EGQRPENKGKNRYKN CCCCCCCCCCCCCCC | 70.38 | - | |
276 | Phosphorylation | ENKGKNRYKNILPFD CCCCCCCCCCCCCCC | 20.13 | 28796482 | |
277 | Acetylation | NKGKNRYKNILPFDH CCCCCCCCCCCCCCC | 33.98 | 19608861 | |
277 | Ubiquitination | NKGKNRYKNILPFDH CCCCCCCCCCCCCCC | 33.98 | 21890473 | |
277 (in isoform 1) | Ubiquitination | - | 33.98 | 21890473 | |
277 | Ubiquitination | NKGKNRYKNILPFDH CCCCCCCCCCCCCCC | 33.98 | 21890473 | |
278 (in isoform 3) | Phosphorylation | - | 31.90 | 27642862 | |
279 (in isoform 3) | Ubiquitination | - | 4.52 | 21890473 | |
285 | Phosphorylation | NILPFDHSRVILQGR CCCCCCCCEEEEECC | 30.04 | 23312004 | |
286 | Methylation | ILPFDHSRVILQGRD CCCCCCCEEEEECCC | 18.97 | 115916953 | |
294 | Phosphorylation | VILQGRDSNIPGSDY EEEECCCCCCCCCCC | 34.99 | 30108239 | |
299 | Phosphorylation | RDSNIPGSDYINANY CCCCCCCCCCCCHHH | 23.14 | 28796482 | |
301 | Phosphorylation | SNIPGSDYINANYIK CCCCCCCCCCHHHHC | 9.58 | 28796482 | |
303 (in isoform 3) | Phosphorylation | - | 18.86 | 27642862 | |
306 | Phosphorylation | SDYINANYIKNQLLG CCCCCHHHHCCCCCC | 15.74 | 28796482 | |
308 | Ubiquitination | YINANYIKNQLLGPD CCCHHHHCCCCCCCC | 28.42 | - | |
308 (in isoform 3) | Phosphorylation | - | 28.42 | 27642862 | |
350 | O-linked_Glycosylation | NSRVIVMTTREVEKG CCEEEEEECCCHHCC | 16.29 | 30379171 | |
352 (in isoform 2) | Ubiquitination | - | 36.48 | 21890473 | |
360 | Ubiquitination | EVEKGRNKCVPYWPE CHHCCCCCCCCCCCC | 34.94 | - | |
364 | Phosphorylation | GRNKCVPYWPEVGMQ CCCCCCCCCCCCCCC | 17.13 | - | |
374 | Phosphorylation | EVGMQRAYGPYSVTN CCCCCEECCCCCCCC | 22.33 | 28796482 | |
377 | Phosphorylation | MQRAYGPYSVTNCGE CCEECCCCCCCCCCC | 16.06 | 28796482 | |
378 | Phosphorylation | QRAYGPYSVTNCGEH CEECCCCCCCCCCCC | 26.12 | 28796482 | |
379 (in isoform 3) | Phosphorylation | - | 3.53 | 27642862 | |
380 | Phosphorylation | AYGPYSVTNCGEHDT ECCCCCCCCCCCCCC | 20.89 | 28796482 | |
387 | Phosphorylation | TNCGEHDTTEYKLRT CCCCCCCCCEEEECE | 24.35 | 28796482 | |
388 | Phosphorylation | NCGEHDTTEYKLRTL CCCCCCCCEEEECEE | 43.29 | 28796482 | |
390 | Phosphorylation | GEHDTTEYKLRTLQV CCCCCCEEEECEEEE | 17.15 | 28796482 | |
391 | Ubiquitination | EHDTTEYKLRTLQVS CCCCCEEEECEEEEC | 25.84 | 2190698 | |
391 (in isoform 1) | Ubiquitination | - | 25.84 | 21890473 | |
393 (in isoform 3) | Ubiquitination | - | 29.28 | 21890473 | |
394 | Phosphorylation | TTEYKLRTLQVSPLD CCEEEECEEEECCCC | 31.79 | 28450419 | |
398 | Phosphorylation | KLRTLQVSPLDNGDL EECEEEECCCCCCHH | 13.54 | 30108239 | |
453 | S-nitrosocysteine | AGPIIVHCSAGIGRT CCCEEEECCCCCCCC | 1.75 | - | |
453 | S-nitrosylation | AGPIIVHCSAGIGRT CCCEEEECCCCCCCC | 1.75 | 22178444 | |
462 | Phosphorylation | AGIGRTGTIIVIDML CCCCCCCEEEEECCC | 13.61 | 28674151 | |
474 | Phosphorylation | DMLMENISTKGLDCD CCCCCCCCCCCCCCC | 35.33 | 28674151 | |
486 | Ubiquitination | DCDIDIQKTIQMVRA CCCCCHHHHHHHHHH | 48.18 | - | |
496 | Phosphorylation | QMVRAQRSGMVQTEA HHHHHHHCCCCCCHH | 21.11 | - | |
509 | Phosphorylation | EAQYKFIYVAIAQFI HHHHHHHHHHHHHHH | 6.22 | 19060867 | |
521 | Ubiquitination | QFIETTKKKLEVLQS HHHHHHHHHHHHHHH | 61.57 | - | |
522 | Ubiquitination | FIETTKKKLEVLQSQ HHHHHHHHHHHHHHC | 51.97 | - | |
528 | Phosphorylation | KKLEVLQSQKGQESE HHHHHHHHCCCCCCC | 29.69 | 24247654 | |
528 (in isoform 4) | Phosphorylation | - | 29.69 | 27251275 | |
530 | Ubiquitination | LEVLQSQKGQESEYG HHHHHHCCCCCCCCC | 68.74 | - | |
530 (in isoform 3) | Phosphorylation | - | 68.74 | 27642862 | |
534 | Phosphorylation | QSQKGQESEYGNITY HHCCCCCCCCCCCCC | 28.38 | 21945579 | |
534 (in isoform 4) | Phosphorylation | - | 28.38 | 27251275 | |
536 | Phosphorylation | QKGQESEYGNITYPP CCCCCCCCCCCCCCH | 25.42 | 21945579 | |
536 (in isoform 3) | Phosphorylation | - | 25.42 | 27642862 | |
536 (in isoform 4) | Phosphorylation | - | 25.42 | 27251275 | |
538 (in isoform 3) | Phosphorylation | - | 23.64 | 27642862 | |
540 | Phosphorylation | ESEYGNITYPPAMKN CCCCCCCCCCHHHHH | 33.69 | 21945579 | |
541 | Phosphorylation | SEYGNITYPPAMKNA CCCCCCCCCHHHHHH | 11.92 | 21945579 | |
543 (in isoform 3) | Phosphorylation | - | 34.27 | 27642862 | |
546 | Ubiquitination | ITYPPAMKNAHAKAS CCCCHHHHHHHHHHH | 53.76 | - | |
553 | Phosphorylation | KNAHAKASRTSSKHK HHHHHHHHCCCHHHH | 35.07 | 26074081 | |
555 | Phosphorylation | AHAKASRTSSKHKED HHHHHHCCCHHHHHH | 34.55 | 23927012 | |
556 | Phosphorylation | HAKASRTSSKHKEDV HHHHHCCCHHHHHHH | 35.96 | 23927012 | |
557 | Phosphorylation | AKASRTSSKHKEDVY HHHHCCCHHHHHHHH | 37.86 | 23401153 | |
557 (in isoform 3) | Phosphorylation | - | 37.86 | 27642862 | |
558 (in isoform 3) | Phosphorylation | - | 59.47 | 24719451 | |
559 (in isoform 3) | Phosphorylation | - | 40.46 | 27642862 | |
560 | Ubiquitination | SRTSSKHKEDVYENL HCCCHHHHHHHHHHH | 60.38 | - | |
563 (in isoform 4) | Phosphorylation | - | 7.28 | - | |
564 | Phosphorylation | SKHKEDVYENLHTKN HHHHHHHHHHHHHCC | 16.06 | 21945579 | |
566 (in isoform 3) | Phosphorylation | - | 21.31 | 25147952 | |
569 | Phosphorylation | DVYENLHTKNKREEK HHHHHHHHCCHHHHH | 39.21 | 21945579 | |
570 | Ubiquitination | VYENLHTKNKREEKV HHHHHHHCCHHHHHH | 50.12 | - | |
582 | Phosphorylation | EKVKKQRSADKEKSK HHHHHHHHHHHHHHC | 38.02 | - | |
588 | Phosphorylation | RSADKEKSKGSLKRK HHHHHHHHCCCCCCC | 43.25 | - | |
591 | Phosphorylation | DKEKSKGSLKRK--- HHHHHCCCCCCC--- | 34.16 | 15269224 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
536 | Y | Phosphorylation | Kinase | ABL1 | P00519 | PhosphoELM |
536 | Y | Phosphorylation | Kinase | INSR | P06213 | PSP |
536 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
536 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
536 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
536 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
536 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
538 | Y | Phosphorylation | Kinase | INSR | P06213 | GPS |
538 | Y | Phosphorylation | Kinase | PDGFRB | P09619 | GPS |
553 | S | Phosphorylation | Kinase | PKG2 | Q13237 | PSP |
556 | S | Phosphorylation | Kinase | PKG2 | Q13237 | PSP |
557 | S | Phosphorylation | Kinase | PKG2 | Q13237 | PSP |
564 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
564 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
564 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
564 | Y | Phosphorylation | Kinase | LYN | P07948 | Uniprot |
564 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
564 | Y | Phosphorylation | Kinase | ABL1 | P00519 | PhosphoELM |
591 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PTN6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PTN6_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-277, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; TYR-64 AND TYR-564,AND MASS SPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-536, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-509, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-536 AND TYR-564, ANDMASS SPECTROMETRY. | |
"Functional interaction between SHPTP1 and the Lyn tyrosine kinase inthe apoptotic response to DNA damage."; Yoshida K., Kharbanda S., Kufe D.; J. Biol. Chem. 274:34663-34668(1999). Cited for: INTERACTION WITH LYN, AND PHOSPHORYLATION AT TYR-564. |